Suppr超能文献

原发性胆汁性肝硬化:人类白细胞抗原II类等位基因DR8的作用

Primary biliary cirrhosis: contribution of HLA class II allele DR8.

作者信息

Gregory W L, Mehal W, Dunn A N, Cavanagh G, Chapman R, Fleming K A, Daly A K, Idle J R, James O F, Bassendine M F

机构信息

Department of Pharmacological Sciences, University of Newcastle upon Tyne, UK.

出版信息

Q J Med. 1993 Jun;86(6):393-9.

PMID:7909617
Abstract

Primary biliary cirrhosis is a chronic cholestatic disease of unknown aetiology which predominantly affects middle-aged women. It is thought to be autoimmune in nature, but unlike many autoimmune diseases no clear HLA association has been described. Several studies have suggested conflicting associations with HLA class II, although a DR8 association is most frequently described. To test the hypothesis that primary biliary cirrhosis is associated with a certain HLA class II locus we genotyped 130 patients with the disease from the north-east region of England and 363 local healthy controls. HLA-DRB1 and confirmatory DQA and DQB genotypes were determined by TaqI restriction fragment DNA length polymorphism analysis. In addition, a polymerase chain reaction technique (double ARMS) was used to investigate the DRB3 locus (DR52) in 98 primary biliary cirrhosis patients and 107 local controls. We found an increased frequency of HLA-DR8 (18.5% vs 9.2%, p < 0.005, relative risk of 2.0 [1.3-3.1]) in the primary biliary cirrhosis group. HLA-DR8-positive primary biliary cirrhosis patients had a higher serum bilirubin level (p = 0.03) than DR8-negative patients. There was no difference in the DR52 frequencies and no association with markers of disease severity. These results support earlier serological findings, although the association between primary biliary cirrhosis and DR8 is weaker than previously described. In addition, DR8-positivity may identify a clinical subgroup with a worse prognosis.

摘要

原发性胆汁性肝硬化是一种病因不明的慢性胆汁淤积性疾病,主要影响中年女性。其本质被认为是自身免疫性的,但与许多自身免疫性疾病不同,尚未发现明确的HLA关联。多项研究表明与HLA II类存在相互矛盾的关联,尽管最常描述的是与DR8的关联。为了验证原发性胆汁性肝硬化与特定HLA II类基因座相关的假设,我们对来自英格兰东北部地区的130例该疾病患者和363名当地健康对照进行了基因分型。通过TaqI限制性片段DNA长度多态性分析确定HLA-DRB1以及确证性的DQA和DQB基因型。此外,采用聚合酶链反应技术(双引物扩增阻滞突变系统)对98例原发性胆汁性肝硬化患者和107名当地对照的DRB3基因座(DR52)进行研究。我们发现原发性胆汁性肝硬化组中HLA-DR8的频率增加(18.5%对9.2%,p<0.005,相对风险为2.0[1.3 - 3.1])。HLA-DR8阳性的原发性胆汁性肝硬化患者血清胆红素水平高于DR8阴性患者(p = 0.03)。DR52频率无差异,且与疾病严重程度标志物无关联。这些结果支持了早期的血清学发现,尽管原发性胆汁性肝硬化与DR8之间的关联比先前描述的要弱。此外,DR8阳性可能识别出预后较差的临床亚组。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验